Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children.
Pediatr Infect Dis J
; 22(3): 216-24, 2003 Mar.
Article
de En
| MEDLINE
| ID: mdl-12634581
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Pyrimidinones
/
Infections à VIH
/
Inhibiteurs de la transcriptase inverse
/
Ritonavir
/
Dose maximale tolérée
Type d'étude:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limites:
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Langue:
En
Journal:
Pediatr Infect Dis J
Sujet du journal:
DOENCAS TRANSMISSIVEIS
/
PEDIATRIA
Année:
2003
Type de document:
Article
Pays d'affiliation:
Panama